Early total white blood cell recovery is a predictor of low number of apheresis and good CD34+ cell yield

Transfusion Science

Volumn 23, Issue 2, 2000, Pages 91-100

  Marques, J F C ^a   Vigorito, A C ^a   Aranha, F J P ^a   Lorand Metze, I ^a   Miranda, E C M ^a   Lima Filho, E C ^a   Valbonesi, M ^b   Santini, G ^b   De Souza, C A ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Apheresis; Chemotherapy and radiotherapy; Haematological malignancies; Peripheral blood progenitor cell mobilisation

Indexed keywords

ANTINEOPLASTIC AGENT; CD34 ANTIGEN; CIPROFLOXACIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; FLUCONAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADOLESCENT; ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CHILD; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; HEMATOPOIETIC SYSTEM TUMOR; HUMAN; HUMAN CELL; INFECTION; LEUKAPHERESIS; LEUKOCYTE COUNT; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIGENS, CD34; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD CELL COUNT; CASPASES; CHILD; CISPLATIN; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; ETOPOSIDE; FEASIBILITY STUDIES; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMAN; INFECTION CONTROL; LEUKAPHERESIS; LEUKOCYTE COUNT; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGE; RECOMBINANT PROTEINS; TIME FACTORS;

EID: 0346384850     PISSN: 09553886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-3886(00)00072-2     Document Type: Article

References (46)

1. Kessinger A, Armitage JO, Landmark JD, et al. Autologous peripheral haematopoietic stem cell transplantation restores hematopoietic function following ablative therapy. Blood 1988;71:723-7.
2. Williams SF, Bitran JD, Richards JM, et al. Peripheral blood-derived stem cell collections for use in autologous transplantation after high-dose chemotherapy: an alternative approach. Bone Marrow Transplant 1990;5:129-33.
3. Kessinger A, Armitage JO, Smith DM, et al. High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma. Blood 1989;74:1260-4.
4. Dreyfus F, Leblond V, Belander C, et al. Peripheral blood stem cell collection and autografting in high risk lymphomas. Bone Marrow Transplant 1992;10:409-13.
5. Santini G, Congiu AM, Nati S, et al. Mobilisation/ transplantation of peripheral blood progenitor cells for aggressive non-Hodgkin's lymphoma with marrow involvement. Leukaemia 1996;10:S88-91.
6. Gianni AM, Siena S, Bregni M, et al. High-dose sequential chemo-radiotherapy with peripheral blood progenitor cell support for relapsed or refractory Hodgkin's disease - a 6-year update. Ann Oncol 1993;4:889-91.
7. Bierman PJ, Vose JM, Armitage JO. Autologous transplantation for Hodgkin's disease: coming of age. Blood 1994;83:1161-4.
8. Fermand J-P, Chevret S, Ravaud P, et al. High-dose chemoradiotherapy and autologous blood stem cell transplantation in multiple myeloma: results of a phase II trial involving 63 patients. Blood 1993;82:2005-9.
9. Marit G, Faberes C, Pico JL, et al. Autologous peripheral-blood progenitor-cell support following high-dose chemotherapy of chemoradiotherapy in patients with high-risk multiple myeloma. J Clin Oncol 1996;14:1306-13.
10. Carella AM, Celesti L, Lerma E, Dejana A, Frassoni F. Stem cell mobilisation for autografting in chronic myeloid leukaemia. Blood Rev 1997;11:154-9.
11. To LB, Haylock DN, Simmons PJ, Juttner CA. The biology and clinical uses of blood stem cells. Blood 1997;89:2233-58.
12. Bensinger W, Appelbaum F, Rowley S, et al. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 1995;13:2547-55.
13. Tricot G, Jagannath S, Vesole DH, et al. Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients. Blood 1995;85:588-96.
14. + cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 1997;19:303-10.
15. Tarella C, Ferrero D, Bregni M, et al. Peripheral blood expansion of early progenitor cells after high-dose cyclophosphamide and rhGM-CSF. Eur J Cancer 1991;27:22-7.
16. 2) and granulocyte colony-stimulating factor in patients with multiple myeloma. Bone Marrow Transplant 1996;17:691-7.
17. Ketterer N, Salles G, Moullet I, et al. Factors associated with successful mobilisation of peripheral blood progenitor cells in 200 patients with lymphoid malignancies. Br J Haematol 1998;103:235-42.
18. Haas R, Mohle R, Fruhauf S, et al. Patient characteristics associated with successful mobilising and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 1994;83:3787-94.
19. Goldschmidt H, Hegenbart U, Wallmeier M, et al. Factors influencing collection of peripheral blood progenitor cells following high-dose cyclophosphamide and granulocyte colony-stimulating factor in patients with multiple myeloma. Br J Haematol 1997;98:736-44.
20. Dreger P, Klöss M, Petersen B, et al. Autologous progenitor cell transplantation: prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts. Blood 1995;86:3970-8.
21. Kotasek D, Shepherd KM, Sage RE, et al. Factors affecting blood stem cell collections following high-dose cyclophosphamide mobilisation in lymphoma, myeloma and solid tumors. Bone Marrow Transplant 1992;9:11-7.
22. Watts MJ, Sullivan AM, Jamieson E, et al. Progenitor-cell mobilisation after low-dose cyclophosphamide and granulocyte colony-stimulating factor: an analysis of progenitor-cell quantity and quality and factors predicting for these parameters in 101 pretreated patients with malignant lymphoma. J Clin Oncol 1997;15:535-46.
23. Schwella N, Siegert W, Beyer J, et al. Autografting with blood progenitor cells: predictive value of preapheresis blood cell counts on progenitor cell harvest and correlation of the reinfused cell dose with hematopoietic reconstitution. Ann Hematol 1995;71:227-34.
24. + cells after stem cell mobilisation predict stem cell yield and posttransplant hematopoietic recovery. J Hematother 1997;6:13-9.
25. Smolowicz AG, Villman K, Tidefelt U. Large volume apheresis for the harvest of peripheral blood progenitor cells for autologous transplantation. Transfusion 1997;37:188-92.
26. - positive peripheral blood cells by a blood cell separator. Transfusion 1998;38:1046-50.
27. Santini G, De Souza C, Congiu AM, et al. High-dose cyclophosphamide followed by autografting can improve the outcome of relapsed or resistant non-Hodgkin's lymphomas with involved or hypoplastic bone marrow. Leuk lymphoma 1999;33:321-30.
28. Velasquez WS, Cabanillas F, Salvador P, et al. Effective salvage therapy for lymphoma with cisplatin in combination with high-dose ara-C and dexamethasone (DHAP). Blood 1988;71:117-22.
29. Carella AM, Frassoni F. ICE, mini-ICE or high-dose hydroxyurea to mobilise Philadelphia [Ph]-negative PBPC in chronic myelogenous leukaemia. Br J Haematol 1996;95:213-4.
30. Caracciolo D, Gavarotti P, Aglietta M, et al. High-dose sequential (HDS) chemotherapy with blood and marrow cell autograft as salvage treatment in very poor prognosis relapsed non-Hodgkin's lymphoma. Bone Marrow Transplant 1993;12:621-5.
31. + cells in peripheral and cord blood by flow cytometry. Exp Hematol 1994;22:1003-110.
32. Armitage P, Berry G. Statistical Methods in Medical Research, 3rd ed. Oxford: Oxford University Press; 1994.
33. Rao CR. Linear models: least squares and alternatives. New York: Springer; 1995. p. 352.
34. + progenitor cell collection in patients with haematological malignancies. Am J Haematol 1998;58:255-62.
35. Gandhi MK, Jestice K, Scott MA, et al. The minimum CD34 threshold depends on prior chemotherapy in autologous peripheral blood stem cell recipients. Bone Marrow Transplant 1999;23:9-13.
36. Valbonesi M. Hemopoietic stem cells: technical and methodological considerations. Stem Cells 1993;October 11(Suppl 3):58-63.
37. To LB, Shepperd KM, Haylock DN, et al. Single high-doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells from the peripheral blood. Exp Hematol 1990;18:442-7.
38. 2 in patients with advanced cancer. Aust N Z J Med 1992;22:660-4.
39. De Luca E, Sheridan WP, Watson D, et al. Prior chemotherapy does not prevent effective mobilisation by G-CSF of peripheral blood progenitor cells. Br J Cancer 1992;66:893-9.
40. Richman C, Weiner R, Yankee R. Increase in circulating stem cell following chemotherapy in man. Blood 1976;47:1031-9.
41. + hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide treated patients: enhancement by intravenous recombinant human granulocyte macrophage colony stimulating factor. Blood 1989;74:1905-14.
42. Haas R, Hohaus S, Egerer G, et al. Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) subsequent to chemotherapy improves collection of blood stem cells for autografting in patients not eligible for bone marrow harvest. Bone Marrow Transplant 1992;9:459-65.
43. Boiron JM, Marit G, Faberes C, et al. Collection of peripheral blood stem cells in multiple myeloma following single high-dose cyclophosphamide with and without recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF). Bone Marrow Transplant 1993;12:49-55.
44. Peters WP, Rosner G, Ross M, et al. Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy. Blood 1993;7:1709-19.
45. Bolwell B, Goormastic M, Yanssens T, et al. Comparison of G-CSF with GM-CSF for mobilising peripheral blood progenitor cells and for enhancing marrow recovery after autologous bone marrow transplant. Bone Marrow Transplant 1994;14:913-8.
46. Krause DS, Mechanic SA, Snyder EL. Mobilisation and collection of peripheral blood progenitor cells. In: McLeod BC, Price TH, editors. Apheresis: Principles and Practice. Bethesda, MD: AABB Press; 1997. p. 433-51.